THE USE OF CRISPR/CAS SYSTEMS AS AN ALTERNATIVE TOOL TO OVERCOME ANTIBIOTIC RESISTANCE
Анотація
Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas (CRISPR-associated proteins) are specific repeating DNA sequences found in the genomes of prokaryotes, such as bacteria and archaea. It is a revolutionary gene-editing technology that enables scientists to precisely modify DNA in living cells. Therefore, this tool has the potential to revolutionize many fields, including medicine, agriculture, and biotechnology, as it can lead to the development of new treatments for genetic disorders, the improvement of crop yields and resistance to pests and diseases, advancements in the production of bioactive compounds, etc.
Посилання
Bikard D, Euler CW, Jiang W, et al. Exploiting CRISPR-Cas nucleases to produce sequencespecific antimicrobials. Nat Biotechnol. 2014; 32(11):46-50. https://doi.org/10.1038/nbt.3043.
Kim JS, Cho DH, Park M, et al. CRISPR/Cas9-mediated re-sensitization of antibiotic-resistant Escherichia coli harboring extended-spectrum β-lactamases. J Microbiol Biotechnol. 2016; 26:394–401. https://doi.org/10.4014/jmb.1508.08080.
Tagliaferri TL, Guimara ̃es NR, Pereira MPM, et al. Exploring the potential of CRISPR-Cas9 under challenging conditions: facing high-copy plasmids and counteracting beta-lactam resistance in clinical strains of Enterobacteriaceae. Front Microbiol. 2020; 11:578. https://doi.org/10.3389/fmicb.2020.00578.
Gholizadeh P, Köse Ş, Dao S, Ganbarov K, Tanomand A, Dal T, Aghazadeh M, Ghotaslou R, Ahangarzadeh Rezaee M, Yousefi B, Samadi Kafil H. How CRISPR-Cas System Could Be Used to Combat Antimicrobial Resistance. Infect Drug Resist. 2020; 13:1111-1121. doi: 10.2147/IDR.S247271.
Roy S, Naha S, Rao A, Basu S. CRISPR-Cas system, antibiotic resistance and virulence in bacteria: Through a common lens. Prog Mol Biol Transl Sci. 2021; 178:123-174. doi: 10.1016/bs.pmbts.2020.12.005.
